In 1953, Dr. Herman Pinkus first described the fibroepithelial tumor of Pinkus (FEP) as a pre-malignant epithelial tumor. Although there has been some dispute over the classification of FEP, its histologic appearance is unique and distinguishes it from other fibroepithelial tumors. Several important distinctions can be made between FEP and basal cell carcinoma (BCC.) Most notable is the presence of Merkel cells in FEP and the absence of those cells in BCC. FEP also occurs more frequently in females and has no association with sun exposure. It typically occurs on the lower trunk; whereas, BCC is more common in sun-exposed areas of the body. From a prognostic standpoint, FEP does not have an aggressive course and has not been reported to invade or metastasize. Basal cell carcinoma, on the other hand, can invade and metastasize if left untreated. This activity reviews the evaluation of premalignant fibroepithelial tumors and identifies the role of the interprofessional team in managing this condition.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/27652
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Dermatopathology, General Pediatrics, General Surgery, Internal Medicine